Detalles de la búsqueda
1.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(1): 88-99, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30509771
2.
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol
; 42(11): 1288-1300, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301187
3.
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
J Natl Cancer Inst
; 115(11): 1302-1309, 2023 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184928
4.
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34599031
5.
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
J Natl Cancer Inst
; 110(2)2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28954297
6.
Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
Int J Oncol
; 41(5): 1570-6, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22922842
7.
Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial.
Cancer Biother Radiopharm
; 23(3): 285-91, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18593361
8.
Surgical management and outcome in primary adenocarcinoma of the small bowel.
Ann Surg Oncol
; 14(8): 2263-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17549572
Resultados
1 -
8
de 8
1
Próxima >
>>